111 research outputs found

    Synthesis of hetero-bifunctional, end-capped oligo-EDOT derivatives

    Get PDF
    Conjugated oligomers of 3,4-ethylenedioxythiophene (EDOT) are attractive materials for tissue engineering applications, and as model systems for studying the properties of the widely used polymer PEDOT. We report here the facile synthesis of a series of keto-acid end-capped oligo-EDOT derivatives (n = 2-7) through a combination of a glyoxylation end capping strategy and iterative direct arylation chain extension. Importantly, these structures not only represent the longest oligo-EDOTs reported, but are also bench stable in contrast to previous reports on such oligomers. The constructs reported here can undergo subsequent derivatization for integration into higher order architectures, such as those required for tissue engineering applications. The synthesis of hetero-bifunctional constructs, as well as those containing mixed monomer units is also reported, allowing further complexity to be installed in a controlled manner. Finally, we describe the optical and electrochemical properties of these oligomers and demonstrate the importance of the keto-acid in determining their characteristics

    A conducting polymer with enhanced electronic stability applied in cardiac models

    No full text
    Electrically active constructs can have a beneficial effect on electroresponsive tissues, such as the brain, heart, and nervous system. Conducting polymers (CPs) are being considered as components of these constructs because of their intrinsic electroactive and flexible nature. However, their clinical application has been largely hampered by their short operational time due to a decrease in their electronic properties. We show that, by immobilizing the dopant in the conductive scaffold, we can prevent its electric deterioration. We grew polyaniline (PANI) doped with phytic acid on the surface of a chitosan film. The strong chelation between phytic acid and chitosan led to a conductive patch with retained electroactivity, low surface resistivity (35.85 ± 9.40 kilohms per square), and oxidized form after 2 weeks of incubation in physiological medium. Ex vivo experiments revealed that the conductive nature of the patch has an immediate effect on the electrophysiology of the heart. Preliminary in vivo experiments showed that the conductive patch does not induce proarrhythmogenic activities in the heart. Our findings set the foundation for the design of electronically stable CP-based scaffolds. This provides a robust conductive system that could be used at the interface with electroresponsive tissue to better understand the interaction and effect of these materials on the electrophysiology of these tissues

    Auxetic cardiac patches with tunable mechanical and conductive properties toward treating myocardial infarction

    Get PDF
    An auxetic conductive cardiac patch (AuxCP) for the treatment of myocardial infarction (MI) is introduced. The auxetic design gives the patch a negative Poisson's ratio, providing it with the ability to conform to the demanding mechanics of the heart. The conductivity allows the patch to interface with electroresponsive tissues such as the heart. Excimer laser microablation is used to micropattern a re-entrant honeycomb (bow-tie) design into a chitosan-polyaniline composite. It is shown that the bow-tie design can produce patches with a wide range in mechanical strength and anisotropy, which can be tuned to match native heart tissue. Further, the auxetic patches are conductive and cytocompatible with murine neonatal cardiomyocytes in vitro. Ex vivo studies demonstrate that the auxetic patches have no detrimental effect on the electrophysiology of both healthy and MI rat hearts and conform better to native heart movements than unpatterned patches of the same material. Finally, the AuxCP applied in a rat MI model results in no detrimental effect on cardiac function and negligible fibrotic response after two weeks in vivo. This approach represents a versatile and robust platform for cardiac biomaterial design and could therefore lead to a promising treatment for MI

    Systemic Resistance in Chickpea (Cicer arietinum L.) Elicited by Some Biotic Inducers Against Root Diseases

    Get PDF
    The effect of seed treatment of chickpea (Cicer arietinum L.) with biotic inducers such as Trichoderma viride, Trichoderma harzianum, Pseudomonas fluorescens and Bacillus subtilis in contrast to the fungicide Rizolex-T, were evaluated in the greenhouse and under field conditions during the 2017/2018 season to control the plant disease caused by Fusarium oxysporum, Rhizoctonia solani, or Sclerotinia sclerotiorum, at Giza Agriculture Research Station, Agricultural Research Center, Giza Governorate, Egypt. The tested strains significantly inhibit the mycelial growth of the three tested fungi for pathogenic growth. Compared to the untreated control under greenhouse and field conditions, all the biotic inducer treatments tested significantly decreased the percentages of damping-off, root rot, stem rot and/or wilt diseases. It was noticed that Rizolex-T and (Trichoderma viride + Trichoderma harzianum) have reached the highest percentage of surviving plants followed by (Pseudomonas fluorescens + Bacillus subtilis), Trichoderma viride, Trichoderma harzianum, Bacillus subtilis, Pseudomonas fluorescens and Serratia marcescens, respectively. As well as all the treatments of the checked biocontrol agents increased the growth and yield parameters of chickpea significantly, i.e., plant hight, branches number per plant, pods number per plant, seeds number per plant, seeds weight per plant, 100 seeds weight, and chickpea yield ton/fed. In the presence of the three studied pathogens, defense-related enzyme activities (β-1,3 glucanase, peroxidase, and polyphenoloxidase) have also been determined in all chickpea plants treated with tested biotic inducers compared to untreated infested and non-infested control. The treatment of (Trichoderma harzianum + Trichoderma viride) showed the highest increase in phenol content and the activities of defense-related enzymes

    Aneurysm Ostium Angle: A Predictor of the Need for Stent as Assistance for Endovascular Aneurysm Coiling in Internal Carotid Artery Sidewall Aneurysms

    Get PDF
    BACKGROUND AND PURPOSE: There is no satisfactory parameter that can predict the need for assistant devices for endovascular aneurysm coiling. Our aim was to evaluate the utility of MOA as a predictor of the need for stent-assisted coiling in ICA sidewall aneurysms

    Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model

    Get PDF
    s / Biol Blood Marrow Transplant 19 (2013) S211eS232 S228 chemotherapy was HIDAC (1-3 grams/m2 for 6-8 doses)/ Etoposide(15-40mg/kg) in 16 patients and growth factor alone in one patient. Median time from diagnosis to ASCT was 4.2 (range 3.6-7) months. Preparative regimen for ASCT was Busulfan (3.2mg/kg x 4)/Etoposide (60 mg/kg) in 12 patients and high dose melphalan in 5 patients. The median CD34 cells infused was 4.9 x 10e6/kg (range 2.8 to 15.9).All patients engrafted with a median time to neutrophil engraftment of 11 (range10-12) days. The median time to platelet engraftment was 20 (range15-40) days. The median length of inpatient stay during the ASCT admission was 14 (range 10-25) days. One patient died of progressive disease 14 months post ASCT. Two patients died in remission on day 53 (sepsis) and day 836 (unknown cause) post ASCT. Fourteen patients (82%) are currently alive in complete remission. at a median follow-up of 20 (range 140) months post ASCT. Conclusion: Consolidation of good risk AML patients with ASCT following induction of complete remission is safe and effective in preventing relapse in good risk AML patients
    • …
    corecore